Sermorelin, GHRP-2 Blend contains 5mg of Sermorelin and 5mg of GHRP-2 in a lyophilized research format.
This material is intended for controlled laboratory research involving growth hormone-releasing hormone receptor and growth hormone secretagogue receptor pathways. Refer to the applicable batch-specific Certificate of Analysis for identity, purity, and analytical testing data.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Sermorelin, GHRP-2 (5mg / 5mg) Blend is a lyophilized research material containing two synthetic peptides used in controlled laboratory investigations of GHRH receptor and growth hormone secretagogue receptor signaling.
The two compounds are supplied together for experimental frameworks that require standardized blend composition, analytical characterization, pathway-assay development, or comparisons with individual-compound and vehicle controls.
Sermorelin, GHRP-2 (5mg / 5mg) Blend – Research Specifications:
| Format | Lyophilized peptide blend |
| Nominal Contents | Sermorelin 5mg and GHRP-2 5mg |
| Sermorelin Identity | Amidated 29-amino-acid peptide corresponding to GHRH (1-29) |
| Sermorelin Sequence | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH₂ |
| Sermorelin Molecular Formula | C₁₄₉H₂₄₆N₄₄O₄₂S, free-peptide form |
| Sermorelin Molecular Weight | 3357.9 g/mol, free-peptide form |
| Sermorelin CAS Number | 86168-78-7 |
| GHRP-2 Identity | Pralmorelin; synthetic hexapeptide |
| GHRP-2 Sequence | H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂ |
| GHRP-2 Molecular Formula | C₄₅H₅₅N₉O₆, free-peptide form |
| GHRP-2 Molecular Weight | 818.0 g/mol, free-peptide form |
| GHRP-2 CAS Number | 158861-67-7 |
| Appearance | Lyophilized powder |
| Purity and Identity | Refer to the batch-specific COA for reported results and analytical methods |
| Storage Conditions | Keep sealed, dry, and protected from heat and light; follow lot-specific documentation |
| Use Classification | Laboratory research use only; not for human or animal consumption |
The stated molecular formulas and molecular weights describe the free-peptide forms. Counterions, salts, residual moisture, and other lot-specific characteristics may affect the measured mass of the supplied material. The applicable COA controls for batch-specific documentation.
Sermorelin is an amidated synthetic peptide corresponding to the first 29 amino acids of human growth hormone-releasing hormone. Laboratory literature commonly examines this peptide in connection with GHRH receptor recognition, receptor-mediated signaling, peptide characterization, and related analytical measurements.
GHRP-2, also identified as pralmorelin or KP-102, is a synthetic hexapeptide associated with the growth hormone secretagogue receptor pathway. Its structure includes D-amino acids and a 2-naphthylalanine residue, distinguishing it from endogenous peptide ligands.
When supplied as a blend, the compounds may be incorporated into controlled experimental designs examining parallel receptor-pathway inputs, time-dependent analytical readouts, binding behavior, or assay-method performance. Research observations are specific to the selected model, controls, protocol, and analytical methodology.
Researchers studying the individual compounds may also review:
Important Research Notice: Batch-specific analytical documentation should be reviewed before experimental use. Researchers are responsible for confirming that the material, analytical methods, storage conditions, and experimental design meet their institutional requirements.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR DIAGNOSTIC, THERAPEUTIC, FOOD, DRUG, COSMETIC, OR SUPPLEMENT USE.
Controlled laboratory models may use the blend to examine time-dependent measurements associated with GHRH receptor and growth hormone secretagogue receptor pathways.
Experimental designs may compare sampling intervals, baseline measurements, vehicle controls, individual compounds, and the combined material. Results should be interpreted only within the validated limits of the selected model and assay.
The blend may be used in laboratory pathway-mapping studies involving GHRH receptor signaling and growth hormone secretagogue receptor signaling.
These investigations may evaluate receptor interaction, intracellular signaling markers, ligand-response relationships, or other predefined analytical endpoints. The material is not supplied for clinical or in-vivo human or veterinary procedures.
Researchers may incorporate the blend into validated assays measuring predefined biochemical or molecular markers associated with GH-axis research models.
Appropriate controls, replicate testing, calibrated instrumentation, and documented acceptance criteria are necessary for interpreting experimental measurements. Laboratory findings must not be represented as evidence of safety, efficacy, or suitability for consumer use.
Comparative studies may evaluate the blend alongside Sermorelin-only, GHRP-2-only, and vehicle-control conditions.
This structure can help researchers distinguish individual-compound measurements from observations recorded under the combined experimental condition. Study variables should be documented in accordance with the laboratory’s approved protocol.
Handle Sermorelin, GHRP-2 Blend according to established laboratory procedures for synthetic peptide materials. Use appropriate containment, contamination controls, calibrated equipment, traceable sample identification, and complete experimental records.
Before beginning laboratory work, review the product label, batch-specific COA, applicable Safety Data Sheet, and institutional procedures. Material identity and suitability should be independently confirmed for the intended analytical method.
Protocol Design Considerations: Experimental results may be affected by sample preparation, assay selection, temperature, light exposure, timing, matrix composition, instrumentation, and control design. These variables should be standardized and recorded before data collection.
This information is provided exclusively as a laboratory research reference. It does not include dosing, administration, clinical-use, or veterinary-use guidance.
Lot-specific Certificates of Analysis provide the analytical information reported for the applicable batch. Depending on the testing completed, documentation may include identity, purity, chromatographic results, mass-spectrometry data, or other quality-control parameters.
Researchers should verify that the COA lot number matches the product label and retain the documentation with procurement, inventory, and experimental records.
Nordsci Peptides supplies Sermorelin, GHRP-2 (5mg / 5mg) Blend exclusively as a laboratory research material. Qualified purchasers should review the product specifications, batch documentation, storage requirements, and institutional restrictions before ordering.
IMPORTANT: Purchase or possession of this material does not authorize human, veterinary, diagnostic, therapeutic, food, drug, cosmetic, or supplement use. The purchaser is responsible for compliance with all applicable laws, regulations, and institutional requirements.
